Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00482630
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
CLG | 2-AMINO-6-[2-(2-AMINOOXY-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.76 | |
AHO | N-ACETYL-N-HYDROXY-L-ORNITHINE | A,B | 1BY5 | 0.73 | |
AHO | N-ACETYL-N-HYDROXY-L-ORNITHINE | A,B,C | 2W6U | 0.73 | |
5FP | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID | A,B | 1XE6 | 0.75 | |
AHE | 2-AMINO-4-[1-CARBOXYMETHYL-CARBAMOYL)- 2-HYDROXYMETHYLSULFANYL-ETHYLCARBAMOYL]- BUTYRIC ACID | A | 3BHM | 0.82 | |
AHE | 2-AMINO-4-[1-CARBOXYMETHYL-CARBAMOYL)- 2-HYDROXYMETHYLSULFANYL-ETHYLCARBAMOYL]- BUTYRIC ACID | A,B | 1MC5 | 0.82 | |
CIR | CITRULLINE | A,B,C,D | 1J21 | 0.71 | |
CIR | CITRULLINE | B | 1KOD | 0.71 | |
CIR | CITRULLINE | A,B,C | 3B3I | 0.71 | |
CIR | CITRULLINE | C | 3DTX | 0.71 | |
CIR | CITRULLINE | A | 2C6Z | 0.71 | |
CIR | CITRULLINE | A,C,E,F | 2W65 | 0.71 | |
CIR | CITRULLINE | A,B | 2JAI | 0.71 | |
CIR | CITRULLINE | P | 3FT2 | 0.71 | |
CIR | CITRULLINE | A,B,C,D | 1J1Z | 0.71 | |
CIR | CITRULLINE | A,B | 1LXY | 0.71 | |
CIR | CITRULLINE | F,H | 1OL1 | 0.71 | |
CIR | CITRULLINE | A | 1KP3 | 0.71 | |
CIR | CITRULLINE | A | 2NZ2 | 0.71 | |
CIR | CITRULLINE | A | 1H70 | 0.71 | |
CIR | CITRULLINE | A | 1K97 | 0.71 | |
CIR | CITRULLINE | C | 3B6S | 0.71 | |
5FE | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID METHYL ESTER | A,B | 1XE5 | 0.74 | |
DLS | DI-ACETYL-LYSINE | A,B,C,D,E,F | 1FVM | 0.73 | |
AOR | N~2~-ACETYL-L-ORNITHINE | A | 1ZQ6 | 0.77 | |
FH7 | N^5^-formyl-N^5^-hydroxy-D-ornithine | A,B,C | 2W6T | 0.72 | |
FH7 | N^5^-formyl-N^5^-hydroxy-D-ornithine | A,B,C | 2W78 | 0.72 | |
FH7 | N^5^-formyl-N^5^-hydroxy-D-ornithine | A,B,C | 2W77 | 0.72 | |
3GC | GAMMA-GLUTAMYLCYSTEINE | A,B | 2BU3 | 0.8 | |
3GC | GAMMA-GLUTAMYLCYSTEINE | A,B | 1M0W | 0.8 | |
DI6 | 3-[(4S)-2,5-DIOXOIMIDAZOLIDIN-4- YL]PROPANOIC ACID | A | 2Q09 | 0.76 | |
074 | [PROPYLAMINO-3-HYDROXY-BUTAN-1,4- DIONYL]-ISOLEUCYL-PROLINE | A | 1QDQ | 0.76 | |
AAG | N-ALPHA-L-ACETYL-ARGININE | A | 1DRY | 0.7 | |
DGN | D-GLUTAMINE | A,D | 2Q3I | 0.7 | |
DGN | D-GLUTAMINE | A,L | 1ZEA | 0.7 | |
DGN | D-GLUTAMINE | A,B | 2FCM | 0.7 | |
DGN | D-GLUTAMINE | A | 1BFW | 0.7 | |
DGN | D-GLUTAMINE | E | 1EPR | 0.7 | |
DGN | D-GLUTAMINE | A | 2JX4 | 0.7 | |
DGN | D-GLUTAMINE | A,B,C,D | 2R3C | 0.7 | |
DGN | D-GLUTAMINE | A,B,C,H,K,L | 2R5D | 0.7 | |
DGN | D-GLUTAMINE | A,B | 2Q33 | 0.7 | |
DGN | D-GLUTAMINE | A,B,C,H,K,L | 2R5B | 0.7 | |
DGN | D-GLUTAMINE | A,B,C | 1YJ1 | 0.7 | |
DGN | D-GLUTAMINE | A | 1B74 | 0.7 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1AEC | 0.7 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A,B | 2PRE | 0.7 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1CV8 | 0.7 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 3C9E | 0.7 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A,B | 3BCN | 0.7 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1ATK | 0.7 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A,B,C,D | 3BPF | 0.7 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1TLO | 0.7 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1QX6 | 0.7 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1MEG | 0.7 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A,B,C,D | 2BDZ | 0.7 | |
52A | (2R,4R)-4-aminopyrrolidine-2,4- dicarboxylic acid | A,B | 2E4Y | 0.72 | |
AN0 | N-ACETYL-L-NORVALINE | C,D,E,X,Y,Z | 2G7M | 0.72 | |
AN0 | N-ACETYL-L-NORVALINE | A | 1ZQ8 | 0.72 | |
CLH | 2-AMINO-6-[2-(2-OXO-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.76 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHA | 0.73 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHB | 0.73 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PPP | 0.78 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PE6 | 0.78 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1ITO | 0.78 |